• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MIGRAINE

Evaluating acute migraine therapies: ICER

March 11, 2020  

New drug approvals in 2020

February 5, 2020  

Future look: Drug approvals pending for 2020

December 5, 2019  

Three new trials of novel headache drugs

August 7, 2019  

FDA approves migraine drug for cluster headaches

June 12, 2019  

AAN 2019 DAILY REPORT

May 9, 2019  

Phase III trials in neurology – 2018 in review

January 24, 2019  

Record number of FDA drug approvals in 2018

January 9, 2019  

New migraine medication approved in Canada

August 6, 2018  

Inhibiting CGRP in migraine prophylaxis

July 25, 2018  
1
2
3

Browse by Topic

  • EPILEPSY (36)
  • MS (412)
  • CLINICAL CASES IN MS (15)
  • AAN 2025 (5)
  • BIOMARKERS IN MS (54)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • CLINICAL CASES IN MS: A 24 Y.O. WOMAN WITH PARESTHESIAE AND NON-ENHANCING LESIONS posted on April 25, 2025
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Ofatumumab – new data on efficacy and safety posted on April 14, 2025
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions